Novel translocations involving TYK2 and ROS-1 in CD30-positive cutaneous lymphoproliferative disorders [64] and systemic ALK-negative ALCL [16] have been previously described. This evidence concerns the gene ROS1 and anaplastic large cell lymphoma.